Chongqing Sansheng Industrial Co.,Ltd. develops, produces and sells building materials and chemicals in China and internationally. It operates through two segments, Buildings Materials Chemical Industry; and Pharmaceutical Manufacturing. The company offers commercial concrete, water reducing agents, and expansion agents for industrial and civil buildings, highways, railways, bridges, tunnels, airports, water conservancy, and hydropower; and sulfuric acid for the production of fertilizers, chemicals, light industry, textile, steel, water reducer, and other non-fertilizer acid enterprises; and concrete admixtures. It also provides pharmaceutical intermediates, such as procaine hydrochloride, cefoxitin acid intermediates, chlorine intermediates, chloramphenicol intermediates, aztreonam intermediates, and orlistat intermediates used in antibiotic drugs, anti-hepatitis C drugs, diabetes drugs, benzathine penicillin and cefoxitin, procaine penicillin, and cosmetics; and API products, including acetaminophen, cloperidine hydrochloride, levofloxacin mesylate, benolate, and diphenhydramine hydrochloride. In addition, the company offers preparation products comprising compound acetaminophen and diphenhydramine tablets, cloperidin hydrochloride tablets, clarithromycin sustained-release tablets, diclofenac sodium enteric-coated tablets, acetaminophen tablets, and famotidine tablets used in antipyretic and analgesic, antiviral, antibacterial, cough, allergy, local anesthesia; and famotidine, diclofenac sodium, nifedipine, acetaminophen, furosemide, norfloxacin used in clinical drugs to meet basic drug needs. The company was formerly known as Chongqing Sansheng Special Building Materials Co., Ltd. and changed its name to Chongqing Sansheng Industrial Co.,Ltd. in October 2016. Chongqing Sansheng Industrial Co.,Ltd. was incorporated in 2002 and is headquartered in Chongqing, China.